Participation of the central p38 and ERK1/2 pathways in IL-1β-induced sensitization of nociception in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 46, Issue , 2013, Pages 98-104

  Yang, Kui Y ^a   Bae, Won S ^a   Kim, Min J ^a   Bae, Yong C ^a   Kim, Young J ^a   Kim, Hyun J ^a   Nam, Soon H ^a   Ahn, Dong K ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Hyperalgesia; IL 1 ; MAPK; Microglia; Sensitization

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEURON SPECIFIC NUCLEAR PROTEIN; OX42 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATORY PAIN; MALE; MICROGLIA; NERVE CELL; NOCICEPTION; NONHUMAN; PROTEIN LOCALIZATION; RAT;

ERK; EXTRACELLULAR SIGNAL-REGULATED KINASE; GFAP; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERALGESIA; IL-1Β; INTERLEUKIN-1Β; MAPK; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE; NEUN; NEURONAL NUCLEI; SENSITIZATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACIAL PAIN; INTERLEUKIN-1BETA; MALE; MAP KINASE SIGNALING SYSTEM; NOCICEPTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880963479     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.07.004     Document Type: Article

References (46)

1. Ahn D.K., Kim Y.S., Park J.S. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 1998, 243:105-108.
2. Ahn D.K., Jung C.Y., Lee H.J., Choi H.S., Ju J.S., Bae Y.C. Peripheral glutamate receptors parcipate in interleukin-1beta-induced mechanical allodynia in the orofacial area of rats. Neurosci Lett 2004, 357:203-206.
3. Ahn D.K., Chae J.M., Choi H.S., Kyung H.M., Kwon O.W., Park H.S., et al. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats. Pain 2005, 117:204-213.
4. Ahn D.K., Kim K.H., Jung C.Y., Choi H.S., Lim E.J., Youn D.H., et al. Role of peripheral group I and II metabotropic glutamate receptors in IL-1beta-induced mechanical allodynia in the orofacial area of conscious rats. Pain 2005, 118:53-60.
5. Basbaum A.I., Bautista D.M., Scherrer G., Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139:267-284.
6. Choi H.S., Ju J.S., Lee H.J., Jung C.Y., Kim B.C., Park J.S., et al. Effects of TNF-alpha injected intracisternally on the nociceptive jaw-opening reflex and orofacial formalin test in freely moving rats. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:613-618.
7. Choi H.S., Ju J.S., Lee H.J., Kim B.C., Park J.S., Ahn D.K. Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Brain Res Bull 2003, 59:365-370.
8. Choi H.S., Lee H.J., Jung C.Y., Ju J.S., Park J.S., Ahn D.K. Central cyclooxygenase-2 participates in interleukin-1 beta-induced hyperalgesia in the orofacial formalin test of freely moving rats. Neurosci Lett 2003, 352:187-190.
9. Clavelou P., Pajot J., Dallel R., Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett 1989, 103:349-353.
10. Cunha J.M., Cunha F.Q., Poole S., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000, 130:1418-1424.
11. Cunha T.M., Verri W.A., Silva J.S., Poole S., Cunha F.Q., Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A 2005, 102:1755-1760.
12. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993, 268:14553-14556.
13. Dinarello C.A. Biology of interleukin 1. FASEB J 1988, 2:108-115.
14. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698-700.
15. Follenfant R.L., Nakamura-Craig M., Henderson B., Higgs G.A. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol 1989, 98:41-43.
16. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 1994, 657:133-140.
17. Gilbert S.D., Clark T.M., Flores C.M. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 2001, 89:159-165.
18. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27:6006-6018.
19. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 2005, 22:2431-2440.
20. Ji R.R., Baba H., Brenner G.J., Woolf C.J. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999, 2:1114-1119.
21. Ji R.R., Befort K., Brenner G.J., Woolf C.J. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 2002, 22:478-485.
22. Ji R.R., Samad T.A., Jin S.X., Schmoll R., Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002, 36:57-68.
23. Jung C.Y., Lee S.Y., Choi H.S., Lim E.J., Lee M.K., Yang G.Y., et al. Participation of peripheral group I and II metabotropic glutamate receptors in the development or maintenance of IL-1beta-induced mechanical allodynia in the orofacial area of conscious rats. Neurosci Lett 2006, 409:173-178.
24. Karim W., Wang C.C., Gereau R.W. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 21:3771-3779.
25. Maier S.F., Wiertelak E.P., Martin D., Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 1993, 623:321-324.
26. Mizushima T., Obata K., Yamanaka H., Dai Y., Fukuoka T., Tokunaga A., et al. Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia. Pain 2005, 113:51-60.
27. Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nat Med 2010, 16:1267-1276.
28. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995, 115:1265-1275.
29. Shimizu K., Asano M., Kitagawa J., Ogiso B., Ren K., Oki H., et al. Phosphorylation of extracellular signal-regulated kinase in medullary and upper cervical cord neurons following noxious tooth pulp stimulation. Brain Res 2006, 1072:99-109.
30. Sommer C., Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004, 361:184-187.
31. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999, 270:25-28.
32. Song J., Wu C., Zhang X., Sorokin L.M. In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1β-induced peritonitis. J Immunol 2013, 190:401-410.
33. Svensson C.I., Marsala M., Westerlund A., Calcutt N.A., Campana W.M., Freshwater J.D., et al. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 2003, 86:1534-1544.
34. Sweitzer S.M., Colburn R.W., Rutkowski M., DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res 1999, 829:209-221.
35. Sweitzer S.M., Peters M.C., Ma J.Y., Kerr I., Mangadu R., Chakravarty S., et al. Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain 2004, 111:278-285.
36. Wang X.M., Zhang Z.J., Bains R., Mokha S.S. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain 2002, 98:27-35.
37. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res 1994, 654:15-26.
38. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 63:289-302.
39. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999, 79:143-180.
40. Willemen H.L., Eijkelkamp N., Wang H., Dantzer R., Dorn G.W., Kelley K.W., et al. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain 2010, 150:550-560.
41. Won K.A., Kang Y.M., Lee M.K., Park M.K., Ju J.S., Bae Y.C., et al. Participation of microglial p38 MAPK in formalin-induced temporomandibular joint nociception in rats. J Orofac Pain 2012, 26:132-141.
42. Woolf C.J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004, 140:441-451.
43. Xie Y.F., Zhang S., Chiang C.Y., Hu J.W., Dostrovsky J.O., Sessle B.J. Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). Brain Behav Immun 2007, 21:634-641.
44. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17:1031-1036.
45. Yang C.S., Jung C.Y., Ju J.S., Lee M.K., Ahn D.K. Intracisternal administration of mitogen-activated protein kinase inhibitors reduced IL-1beta-induced mirror-immage mechanical allodynia in the orofacial area of rats. Neurosci Lett 2005, 387:32-37.
46. Yang G.Y., Woo Y.W., Park M.K., Bae Y.C., Ahn D.K., Bonfa E. Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats. J Orofac Pain 2010, 24:203-211.